相关实验视频

Updated: Jul 1, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.4K

美国患有未经2L干细胞移植治疗的扩散性大B细胞淋巴瘤的患者的治疗模式和费用

Teofilia Acheampong1, Tao Gu1, Trong Kim Le1

  • 1Bristol Myers Squibb, 3401 Princeton Pike, Lawrenceville, NJ 08648, USA.

Future oncology (London, England)
|January 17, 2024
PubMed
概括

不接受干细胞移植的扩散性大B细胞淋巴瘤 (DLBCL) 患者承担了大量的医疗费用和资源使用,主要来自住院治疗. 需要新的治疗方法来减少这种临床和经济负担.

关键词:
在R-CHOP中,使用R-CHOP.化疗 化疗是一种化学疗法.费用 费用 费用 费用 费用 费用 费用 费用扩散大的B细胞淋巴瘤.卫生经济学和结果研究研究.医疗保健资源利用率 医疗保健资源利用率造血干细胞移植 造血干细胞移植大型B细胞淋巴瘤治疗模式 治疗模式

更多相关视频

Enhancing Tumor Content through Tumor Macrodissection10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.0K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

532

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...